Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer

By Guppy Amy   Jamal-Hanjani Mariam   Pickering Lisa  

Future Oncology, Vol. 7, Iss. 6, 2011-06 ,pp. : 727-736

Future Medicine

Access to resources Recommend Favorite

Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha

By Miyake Kotaro   Tsuchida Kunihiro   Sugino Hiromu   Imura Satoru   Morine Yuji   Fujii Masahiko   Shimada Mitsuo  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 113-126

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug

By Urata Yoshiko   Negoro Shunichi   Satouchi Miyako   Kurata Takayasu   Yoshimura Sho   Shimada Temiko   Takada Yoshiki  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 103-107

Humana Press, Inc

Access to resources Recommend Favorite

Anti-Cancer Agent-Induced Nephrotoxicity

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 7, 2014-01 ,pp. : 921-927

Bentham Science Publishers

Access to resources Recommend Favorite

Doxycycline as Potential Anti-cancer Agent

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 12, 2018-01 ,pp. : 1617-1623

Bentham Science Publishers

Access to resources Recommend Favorite